Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD

被引:6
作者
Wang, Bin [1 ]
Li, Fang [1 ]
Guo, Jingjing [1 ]
Wang, Changmei [1 ]
Xu, Dashuai [1 ]
Li, Congcong [1 ]
机构
[1] Shandong Univ, Jinan Cent Hosp, Dept Geriatr, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China
关键词
nonalcoholic fatty liver disease; insulin resistance; coronary heart disease; inflammatory factors; HEPATIC STEATOSIS; ADIPOSE-TISSUE; RISK-FACTORS; FAT; PATHOGENESIS; ASSOCIATION; PREVALENCE;
D O I
10.3892/etm.2018.7043
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Effects of liver function, insulin resistance (IR) and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease (CHD) patients complicated with non-alcoholic fatty liver disease (NAFLD) were investigated. A total of 80 patients with CHD treated in Jinan Central Hospital from October 2016 to July 2017 were randomly enrolled and divided into the NAFLD group (n=41) and the simple CHD group (n=39). The IR, the vascular endothelial dilation function and the related inflammatory factors were also detected, followed by statistical analysis. The level of high-sensitivity C-reactive protein (hs-CRP), serum total bilirubin and alanine aminotransferase (ALT) levels and body mass index in the NAFLD group was decreased and the expression of tumor necrosis factor- was increased compared with that in the simple CHD group (P<0.05). There was a linearly positive correlation between ALT and brachial artery diameter in the NAFLD group (r=0.311, P<0.05). There was a correlation between homeostasis model assessment-IR (HOMA-IR) and HOMA- indexes and brachial artery diameter, hs-CRP and brachial artery diameter in both groups (r=-0.128, r=0.219, P<0.05). The HOMA indexes in the NAFLD group were increased compared with those in the simple CHD group (P<0.01). There were significant differences in the intima-media thickness, number of carotid plaques and detection rate of carotid plaques (P<0.05). The risk of cardiovascular events within 10 years in the NAFLD group was increased compared with that in the simple CHD group. The differences of incidence of cardiovascular diseases (CVD)s were statistically significant (P<0.05). Therefore, The changes in liver function indexes, IR and related inflammatory factors in CHD patients complicated with NAFLD significantly affect the vascular endothelial dilation function, which also have some effects on the occurrence of CVDs.
引用
收藏
页码:1306 / 1311
页数:6
相关论文
共 20 条
  • [1] Prevalence of and risk factors for hepatic steatosis in northern Italy
    Bellentani, S
    Saccoccio, G
    Masutti, F
    Crocè, LS
    Brandi, G
    Sasso, F
    Cristanini, G
    Tiribelli, C
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) : 112 - 117
  • [2] Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
    Bhatia, Lokpal S.
    Curzen, Nicholas P.
    Calder, Philip C.
    Byrne, Christopher D.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (10) : 1190 - +
  • [3] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [4] Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
    Bugianesi, E
    Gastaldelli, A
    Vanni, E
    Gambino, R
    Cassader, M
    Baldi, S
    Ponti, V
    Pagano, G
    Ferrannini, E
    Rizzetto, M
    [J]. DIABETOLOGIA, 2005, 48 (04) : 634 - 642
  • [5] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. GASTROENTEROLOGY, 2012, 142 (07) : 1592 - 1609
  • [6] Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
    Chapman, M. John
    Ginsberg, Henry N.
    Amarenco, Pierre
    Andreotti, Felicita
    Boren, Jan
    Catapano, Alberico L.
    Descamps, Olivier S.
    Fisher, Edward
    Kovanen, Petri T.
    Kuivenhoven, Jan Albert
    Lesnik, Philippe
    Masana, Luis
    Nordestgaard, Borge G.
    Ray, Kausik K.
    Reiner, Zeljko
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale
    Tybjaerg-Hansen, Anne
    Watts, Gerald F.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 (11) : 1345 - 1361
  • [7] Pathogenesis of steatohepatitis
    Day, CP
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) : 663 - 678
  • [8] Souza Mônica Rodrigues de Araújo, 2012, Arq. Gastroenterol., V49, P89, DOI 10.1590/S0004-28032012000100015
  • [9] Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
    Fabbrini, Elisa
    Magkos, Faidon
    Mohammed, B. Selma
    Pietka, Terri
    Abumrad, Nada A.
    Patterson, Bruce W.
    Okunade, Adewole
    Klein, Samuel
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (36) : 15430 - 15435
  • [10] Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
    Fracanzani, Anna Ludovica
    Valenti, Luca
    Bugianesi, Elisabetta
    Andreoletti, Marco
    Colli, Agostino
    Vanni, Ester
    Bertelli, Cristina
    Fatta, Erika
    Bignamini, Daniela
    Marchesini, Giulio
    Fargion, Silvia
    [J]. HEPATOLOGY, 2008, 48 (03) : 792 - 798